000 01572 a2200457 4500
005 20250516001902.0
264 0 _c20110131
008 201101s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00712-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNeely, Michael
245 0 0 _aPharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cNov 2010
300 _a4619-25 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAtazanavir Sulfate
650 0 4 _aDrug Interactions
650 0 4 _aFemale
650 0 4 _aHIV Integrase Inhibitors
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOligopeptides
_xblood
650 0 4 _aPyridines
_xblood
650 0 4 _aPyrrolidinones
_xblood
650 0 4 _aRaltegravir Potassium
650 0 4 _aYoung Adult
700 1 _aDecosterd, Laurent
700 1 _aFayet, Aurélie
700 1 _aLee, Janice Soo Fern
700 1 _aMargol, Ashley
700 1 _aKanani, Meera
700 1 _adi Iulio, Julia
700 1 _avon Schoen-Angerer, Tido
700 1 _aJelliffe, Roger
700 1 _aCalmy, Alexandra
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 54
_gno. 11
_gp. 4619-25
856 4 0 _uhttps://doi.org/10.1128/AAC.00712-10
_zAvailable from publisher's website
999 _c20155762
_d20155762